Research priorities for global measles and rubella control and eradication☆

Goodson, James L.; Chu, Susan Y.; Rota, Paul A.; Moss, William J.; Featherstone, David A.; Vijayaraghavan, Maya; Thompson, Kimberly M.; Martin, Rebecca; Reef, Susan; Strebel, Peter M.

doi:10.1016/j.vaccine.2012.04.058

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Research priorities for global measles and rubella control and eradication☆

7 06 2012
By Goodson, James L. ; Chu, Susan Y. ; Rota, Paul A. ; ...
http://dx.doi.org/10.1016/j.vaccine.2012.04.058
Source: Vaccine. 30(32):4709-4716

[PDF-356.07 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Vaccine
Personal Author:

Goodson, James L. ; Chu, Susan Y. ; Rota, Paul A. ; Moss, William J. ; Featherstone, David A. ; ... More +

Goodson, James L. ; Chu, Susan Y. ; Rota, Paul A. ; Moss, William J. ; Featherstone, David A. ; Vijayaraghavan, Maya ; Thompson, Kimberly M. ; Martin, Rebecca ; Reef, Susan ; Strebel, Peter M. Less -
Description:

In 2010, an expert advisory panel convened by the World Health Organization to assess the feasibility of measles eradication concluded that (1) measles can and should be eradicated, (2) eradication by 2020 is feasible if measurable progress is made toward existing 2015 measles mortality reduction targets, (3) measles eradication activities should occur in the context of strengthening routine immunization services, and (4) measles eradication activities should be used to accelerate control and elimination of rubella and congenital rubella syndrome (CRS). The expert advisory panel also emphasized the critical role of research and innovation in any disease control or eradication program. In May 2011, a meeting was held to identify and prioritize research priorities to support measles and rubella/CRS control and potential eradication activities. This summary presents the questions identified by the meeting participants and their relative priority within the following categories: (1) measles epidemiology, (2) vaccine development and alternative vaccine delivery, (3) surveillance and laboratory methods, (4) immunization strategies, (5) mathematical modeling and economic analyses, and (6) rubella/CRS control and elimination.
Subjects:

[+]

Biomedical Research Cost Of Illness Disease Eradication Global Health Humans Immunization Programs Measles Measles Vaccine Models, Theoretical Rubella Rubella Syndrome, Congenital Rubella Vaccine
Keywords:

[+]

Eradication Immunization Research Vaccines
Source:

Vaccine. 30(32):4709-4716
Pubmed ID:

22549089
Pubmed Central ID:

PMC10321687
Document Type:

Journal Article
Funding:

CC999999/ImCDC/Intramural CDC HHSUnited States/
Volume:

30
Issue:

32
Collection(s):

CDC Public Access
Main Document Checksum:

[+]

urn:sha-512:630e31f672cc4c0ab1d849c65ffcdac955e0a8a164ef15b8f1ade4f28e0808196445cac6ebb061187c72c9b22aaacfe0f56d247d63ee1a2052b3cc1fd43bc296
Download URL:

https://stacks.cdc.gov/view/cdc/130712/cdc_130712_DS1.pdf
File Type:

	nihms-1904059.nxml	xml
	NIHMS1904059-supplement-Appendix_A.pdf	pdf
	NIHMS1904059-supplement-Supplementary_Material.docx	docx

More +